Impact of antithrombin III and enoxaparin dosage adjustment on prophylactic anti-Xa concentrations in trauma patients at high risk for venous thromboembolism: a randomized pilot trial

Byrne JP, Geerts W, Mason SA et al (2017) Effectiveness of low-molecular-weight heparin versus unfractionated heparin to prevent pulmonary embolism following major trauma: a propensity-matched analysis. J Trauma Acute Care Surg 82:252–262 Jacobs BN, Cain-Neilson AH, Jakubus JL et al (2017) Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma. J Trauma Acute Care Surg 83:151–158 Geerts WH, Jay RM, Code KI et al (1996) A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 335:701–707 Knudson MM, Morabito D, Paiement GD, Shakleford S (1996) Use of low molecular weight heparin in preventing thromboembolism in trauma patients. J Trauma 41:446–459 Velhamos GC, Nigro J, Tatevossiam R et al (1998) Inability of an aggressive policy of thromboprophylaxis to prevent deep venous thrombosis (DVT) in critically injured patients: are current methods of DVT prophylaxis insufficient? J Am Coll Surg 187:529–533 Cothren CC, Smith WR, Moore EE, Morgan SJ (2007) Utility of once-daily dose of low-molecular-weight heparin to prevent venous thromboembolism in multisystem trauma patients. World J Surg 31:98–104 Arnold JD, Dart BW, Barker DE et al (2010) Unfractionated heparin three times a day versus enoxaparin in the prevention of deep venous thrombosis in trauma patients. Am Surg. 76(6):563–70 Falck-Ytter Y, Francis CW, Johanson NA et al (2012) Prevention of VTE in Orthopedic Surgery Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 141(2):e278S-325S Gould MK, Garcia DA, Wren SM et al (2012) Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 (Suppl)):e227S – e277 Rogers FB, Cipolle MD, Velmahos G, Rozycki G, Luchette FA (2002) Practice management guidelines for the prevention of venous thromboembolism in trauma patients: The EAST practice management guidelines work group. J Trauma 53(1):142–164 Bush S, LeClaire A, Hampp C, Lottenberg L (2011) Once- versus twice-daily enoxaparin for venous thromboembolism prophylaxis in high-risk trauma patients. J Intensive Care Med 26(2):111–115 Norwood SH, McAuley CE, Berne JD et al (2001) A potentially expanded role for enoxaparin in preventing venous thromboembolism in high risk blunt trauma patients. J Am Coll Surg 192:161–167 Devlin JW, Tyburski JG, Moed B (2001) Implementation and evaluation of guidelines for use of enoxaparin as deep vein thrombosis prophylaxis after major trauma. Pharmacotherapy 21(6):740–747 Om SP, Oswanski MF, Joseph RJ et al (2007) Venous thromboembolism in trauma patients. Am Surg 73:1173–1180 Knudson MM, Ikossi DG, Khaw L, Morabito D, Speetzen LS (2004) Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg 240(3):490–498 Malinoski D, Jafari F, Ewing T et al (2010) Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients. J Trauma 68(4):874–880 Constantini TW, Min E, Box K et al (2013) Dose adjusting enoxaparin is necessary to achieve adequate venous thromboembolism prophylaxis in trauma patients. J Trauma Acute Care Surg 74(1):128–133 Kopelman TR, O’Neill PJ, Pieri PG et al (2013) Alternative dosing of prophylactic enoxaparin in the trauma patient: is more the answer? Am Journal Surg 206:911–916 Nunez JM, Becher RD, Rebo GJ et al (2015) Prospective evaluation of weight-based prophylactic enoxaparin dosing in critically ill trauma patients: adequacy of antiXa levels is improved. Am Surg 81:605–609 Rostas JW, Brevard SB, Ahmed N et al (2015) Standard dosing of enoxaparin for venous thromboembolism prophylaxis is not sufficient for most patients within a trauma intensive care unit. Am Surg 81:889–892 Berndtson AE, Constantini TW, Lane J, Box K, Coimbra R (2016) If some is good, more is better: an enoxaparin dosing strategy to improve pharmacologic venous thromboembolism prophylaxis. J Trauma Acute Care Surg 81:1095–1100 Ko A, Harada MY, Barmpara G et al (2016) Association between enoxaparin dosage adjusted by anti-factor Xa through level and clinically evident venous thromboembolism after trauma. JAMA Surg 151(11):1006–1013 Chapman SA, Irwin ED, Reicks P, Beilman GJ (2016) Non-weight-based enoxaparin dosing subtherapeutic in trauma patients. J Surg Res 201:181–187 Singer GA, Riggi G, Karcutskie CA et al (2016) Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients. J Trauma Acute Care Surg 81:1101–1108 Karcutskie CA, Dharmaraja A, Patel J et al (2017) Relation of antifactor-Xa peak levels and venous thromboembolism after trauma. J Trauma Acute Care Surg 83:1102–1107 Karcutskie CA, Dharmaraja A, Patel J et al (2018) Association of anti-factor Xa-guided dosing of enoxaparin with venous thromboembolism after trauma. JAMA Surg 153(2):144–149 Kopelman TR, Walters JW, Bogert JN et al (2017) Goal directed enoxaparin dosing provides superior chemoprophylaxis against deep vein thrombosis. Injury 48:1088–1092 Dhillon NK, Smith EJT, Gillette E et al (2018) Trauma patients with lower extremity and pelvic fractures: should anti-factor Xa trough level guide prophylactic enoxaparin dose? Int J Surg 51:128–132 Kay AB, Majercik S, Sorensen J et al (2018) Weight-based enoxaparin dosing and deep vein thrombosis in hospitalized trauma patients: a double-blind, randomized, pilot study. Surgery 164(1):144–149 Imran JB, Madni TD, Clark AT et al (2018) Inability to predict subprophylactic anti-factor Xa levels in trauma patients receiving early low-molecular-weight heparin. J Trauma Acute Care Surg 85:867–872 Bethea A, Adams E, Lucente FC, Samanta D, Chumbe JT (2018) Improving pharmacologic prevention of VTE in trauma: IMPACT-IT QI project. Am Surg 84:1097–1104 Rutherford EJ, Schooler WG, Sredzienski E, Abrams JE, Skeete DA (2005) Optimal dose of enoxaparin in critically ill trauma and surgical patients. J Trauma 58:1167–1170 Droege ME, Mueller EW, Besl KM et al (2014) Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients. J Trauma Acute Care Surg 76:450–456 Haas CE, Nelsen JL, Raghavendran K et al (2005) Pharmacokinetics and pharmacodynamics of enoxaparin in multiple trauma patients. J Trauma 59(6):1336–1343 Liener UC, Bruckner UB, Strecker W et al (2001) Trauma severity-dependent changes in AT-III activity. Shock 15(5):344–347 Miller RS, Weatherford DA, Stein D, Crane MM, Stein M (1994) Antithrombin III and trauma patients: factors that determine low levels. J Trauma 37(3):442–445 Owings JT, Bagley M, Gosselin R, Romac D, Disbrow E (1996) Effect of critical injury on plasma antithrombin activity: low antithrombin levels are associated with thromboembolic complications. J Trauma 41(3):396–405 Floccard B, Rugeri L, Faure A et al (2012) Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury 43:26–32 Scherer R, Spangenberg P (1998) Procoagulant activity in patients with isolated severe head trauma. Crit Care Med 26(1):149–156 Waydhas C, Nast-Kolb D, Gippner-Steppert C et al (1998) High-dose antithrombin III treatment of severely injured patients: results of a prospective study. J Trauma 45(5):931–940 Wilson RF, Mammen EF, Tyburski JG, Warsow KM, Kubinec SM (1996) Antithrombin levels related to infections and outcome. J Trauma 40(3):384–387 Connelly CR, Van PY, Hart KD et al (2016) Thromboelastograpy-based dosing of enoxaparin for thromboprophylaxis in trauma and surgical patients: a randomized clinical trial. JAMA Surg 151(10):1–8 Louis SG, Van PY, Riha GM et al (2014) Thromboelasogram-guided enoxaparin dosing dose not confer protection from deep venous thrombosis: a randomized controlled pilot trial. J Trauma Acute Care Surg 76(4):937–942 Robinson S, Zincuk A, Larsen UL et al (2013) A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: a double-blinded, randomized controlled trial. Crit Care 17:1–8 Greenfield LJ, Proctor MC, Rodriguez JL et al (1997) Posttrauma thromboembolism prophylaxis. J Trauma 42:100–103 Baker JE, Niziolek GM, Elson NC et al (2019) Optimizing lower extremity duplex ultrasound screening after traumatic injuries. J Surg Res 243:143–150 Baker SP, O’Neill B, Haddon W, Long WB (1974) The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 14(3):187–196 Ley EJ, Brown CV, Moore EE et al (2020) Updated guidelines to reduce venous thromboembolism in trauma patients: a Western Trauma Association Critical Decisions Algorithm. J Trauma Acute Care Surg. 89(5):971